An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022250
Company: ACORDA

Medication Guide

Other Important Information from FDA

Products on NDA 022250

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AMPYRA	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022250

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/22/2010	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022250s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022250s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022250s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/18/2021	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022250Orig1s019ltr.pdf
02/24/2021	SUPPL-18	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022250Orig1s018ltr.pdf
12/19/2019	SUPPL-17	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/22250s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022250Orig1s017ltr.pdf
09/29/2017	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022250s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022250Orig1s015ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022250Orig1s015ltr.pdf
10/13/2016	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022250s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022250Orig1s013ltr.pdf
08/22/2014	SUPPL-10	Manufacturing (CMC)		Label is not available on this site.
06/18/2013	SUPPL-8	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022250Orig1s008ltr.pdf
12/21/2012	SUPPL-7	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022250Orig1s007ltr.pdf
01/22/2013	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022250Orig1s006ltr.pdf
07/20/2012	SUPPL-4	REMS-Modified, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s003s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022250Orig1s004ltr.pdf
07/20/2012	SUPPL-3	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s003s004lbl.pdf
11/17/2011	SUPPL-2	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022250s002ltr.pdf
09/30/2014	SUPPL-1	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 022250

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/18/2021	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf
02/24/2021	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s018lbl.pdf
12/19/2019	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/22250s017lbl.pdf
09/29/2017	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022250s015lbl.pdf
10/13/2016	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022250s013lbl.pdf
01/22/2013	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf
12/21/2012	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s007lbl.pdf
07/20/2012	SUPPL-4	REMS-Modified	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s003s004lbl.pdf
07/20/2012	SUPPL-4	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s003s004lbl.pdf
07/20/2012	SUPPL-3	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022250s003s004lbl.pdf
01/22/2010	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022250s000lbl.pdf

Therapeutic Equivalents for NDA 022250

AMPYRA

TABLET, EXTENDED RELEASE;ORAL; 10MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AMPYRA	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	022250	ACORDA
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	206863	ACCORD HLTHCARE
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	206836	ACTAVIS LABS FL INC
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	206765	ALKEM LABS LTD
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	206811	AUROBINDO PHARMA
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	210158	MICRO LABS
DALFAMPRIDINE	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	208292	SUN PHARM

Top